Evaluation of the Valiant Mona LSA Thoracic Stent Graft System in Thoracic Aortic Aneurysms and Chronic Dissections

NAWithdrawnINTERVENTIONAL
0
Timeline

Start Date

January 31, 2019

Primary Completion Date

March 31, 2021

Study Completion Date

February 28, 2026

Conditions
Aortic Aneurysm, Thoracic
Interventions
DEVICE

Valiant Mona LSA Thoracic Stent Graft System

The Valiant Mona LSA device is a modular two-component system consisting of a main stent graft (MSG) and a branch stent graft (BSG), delivered separately, designed to maintain LSA perfusion. Briefly, under general anesthesia and after heparin injection, a MSG access is achieved via a femoral artery. A Through-and-through wire access for delivery of the BSG is achieved via a brachial artery. After the placement of the main aortic stent graft in the arch with the cuff at the level of the ostium of the LSA, the BSG is placed through a femoral access.

Trial Locations (2)

13385

Hôpital Timone Adultes, Marseille

31059

CHU Toulouse, Hôpital Rangueil, Toulouse

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Medtronic Vascular

INDUSTRY

lead

University Hospital, Toulouse

OTHER